MTHFR and breast carcinoma: However, it is worth mentioning that the pursuit of correlation between the rs1801133 polymorphism of methylenetetrahydrofolate reductase and breast cancer susceptibility has produced varied outcomes, underscoring the contextual complexities inherent in such analyses.